Tag: HIV
-
Colombia takes significant next step to expand people’s access to affordable HIV treatment, and moves forward with compulsory license for HIV medicine dolutegravir
MSF Bogotá/Geneva, 6 February 2024 – On Friday, the government of Colombia took a historic step towards issuing its first-ever compulsory license (CL) to overcome patent barriers to HIV treatment and import less expensive generic versions of the HIV medicine dolutegravir without permission from the patent owner, ViiV Healthcare (a joint venture of GlaxoSmithKline, Pfizer and Shionogi). The…
